Condition
Internal Hemorrhoid
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Unknown2
Clinical Trials (5)
Showing 5 of 5 trials
NCT06106269RecruitingPrimary
Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
NCT04169152RecruitingPrimary
CAES for Internal Hemorrhoids and Rectal Prolapse
NCT03917056Not ApplicableRecruitingPrimary
Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse
NCT06250140UnknownPrimary
Recurrence Rate of Minimally Invasive Endoscopic Treatment of Internal Hemorrhoids
NCT06031740Not ApplicableUnknown
A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids
Showing all 5 trials